Multiple-year overview of results of operations and balance sheet
20181)
20191)
20201)
2021
2022
375,405
446,437
500,925
618,034
751,488
(263,389)
(313,546)
(375,181)
(466,491)
(577,383)
112,016
132,891
125,743
151,543
174,065
(35,619)
(58,432)
(63,945)
(72.200)
(76,642)
(56,820)
(66,433)
(77,205)
(105.445)
(156,190)
-
(1,647)
-
-
-
(4,364)
(10,272)
(3,244)
(683)
-
15,400
-
-
-
-
47,042
66,600
67,207
67,781
81,580
77,655
62,707
48,556
40,996
20,850
(5,464)
(6,032)
(22,716)
195,984
(174,807)
71,191
56,675
25,840
236,980
(153,957)
12,007
(19,363)
(19,562)
(21,470)
(21,698)
84,198
37,312
6,278
215,510
(175,655)
149,449
320,022
481,930
858,234
718,489
48,030
83,616
87,896
134,721
171,799
5,660
10,749
13,585
25,793
29,825
42,807
33,779
24,392
17,359
10,327
90,519
239,229
337,297
484,597
650,201
122,989
116,994
98,036
30,851
23,819
220,791
255,919
247,370
257,569
274,819
91,116
120,053
171,831
426,037
377,968
771,883
1,180,361
1,462,337
2,235,161
2,257,247
114,465
463,099
491,965
512,917
506,674
31,137
31,319
42,549
72,598
97,277
47,943
53,553
62,579
57,281
70,837
112,228
104,852
88,914
145,537
329,058
41,208
48,925
51,874
69,143
66,217
426,380
478,613
724,456
1,377,685
1,187,185
771,361
1,180,361
1,462,337
2,235,161
2,257,247
2,617
3,030
3,572
4,198
4,952
0.56/0.57
0.25/0.25
0.04/0.04
1.30/1.30
(0.99)/(0.99)
Results of operations: | |
20181) | |
20191) | |
20201) | |
2021 | |
2022 | |
Group revenues | |
20181) | 375,405 |
20191) | 446,437 |
20201) | 500,925 |
2021 | 618,034 |
2022 | 751,488 |
Costs of revenue | |
20181) | (263,389) |
20191) | (313,546) |
20201) | (375,181) |
2021 | (466,491) |
2022 | (577,383) |
Gross profit | |
20181) | 112,016 |
20191) | 132,891 |
20201) | 125,743 |
2021 | 151,543 |
2022 | 174,065 |
R&D expenses | |
20181) | (35,619) |
20191) | (58,432) |
20201) | (63,945) |
2021 | (72.200) |
2022 | (76,642) |
SG&A expenses | |
20181) | (56,820) |
20191) | (66,433) |
20201) | (77,205) |
2021 | (105.445) |
2022 | (156,190) |
Impairment of goodwill (net) | |
20181) | - |
20191) | (1,647) |
20201) | - |
2021 | - |
2022 | - |
Impairment of intangible assets (net) | |
20181) | (4,364) |
20191) | (10,272) |
20201) | (3,244) |
2021 | (683) |
2022 | - |
Income from bargain purchaise | |
20181) | 15,400 |
20191) | - |
20201) | - |
2021 | - |
2022 | - |
Other Operating income (and expenses), net | |
20181) | 47,042 |
20191) | 66,600 |
20201) | 67,207 |
2021 | 67,781 |
2022 | 81,580 |
Operating result | |
20181) | 77,655 |
20191) | 62,707 |
20201) | 48,556 |
2021 | 40,996 |
2022 | 20,850 |
Non-operating income and (expenses), net | |
20181) | (5,464) |
20191) | (6,032) |
20201) | (22,716) |
2021 | 195,984 |
2022 | (174,807) |
Profit (loss) before taxes | |
20181) | 71,191 |
20191) | 56,675 |
20201) | 25,840 |
2021 | 236,980 |
2022 | (153,957) |
Tax income (expense) | |
20181) | 12,007 |
20191) | (19,363) |
20201) | (19,562) |
2021 | (21,470) |
2022 | (21,698) |
Net income | |
20181) | 84,198 |
20191) | 37,312 |
20201) | 6,278 |
2021 | 215,510 |
2022 | (175,655) |
20181) | |
20191) | |
20201) | |
2021 | |
2022 | |
Balance sheet data: | |
20181) | |
20191) | |
20201) | |
2021 | |
2022 | |
Cash, cash equivalents and investments | |
20181) | 149,449 |
20191) | 320,022 |
20201) | 481,930 |
2021 | 858,234 |
2022 | 718,489 |
Trade accounts receivable incl. related parties | |
20181) | 48,030 |
20191) | 83,616 |
20201) | 87,896 |
2021 | 134,721 |
2022 | 171,799 |
Inventories | |
20181) | 5,660 |
20191) | 10,749 |
20201) | 13,585 |
2021 | 25,793 |
2022 | 29,825 |
Deferred tax assets | |
20181) | 42,807 |
20191) | 33,779 |
20201) | 24,392 |
2021 | 17,359 |
2022 | 10,327 |
Property, plant and equipment | |
20181) | 90,519 |
20191) | 239,229 |
20201) | 337,297 |
2021 | 484,597 |
2022 | 650,201 |
Intangible assets, excluding goodwill | |
20181) | 122,989 |
20191) | 116,994 |
20201) | 98,036 |
2021 | 30,851 |
2022 | 23,819 |
Goodwill | |
20181) | 220,791 |
20191) | 255,919 |
20201) | 247,370 |
2021 | 257,569 |
2022 | 274,819 |
Other assets2) | |
20181) | 91,116 |
20191) | 120,053 |
20201) | 171,831 |
2021 | 426,037 |
2022 | 377,968 |
Total assets | |
20181) | 771,883 |
20191) | 1,180,361 |
20201) | 1,462,337 |
2021 | 2,235,161 |
2022 | 2,257,247 |
Loans and finance leases | |
20181) | 114,465 |
20191) | 463,099 |
20201) | 491,965 |
2021 | 512,917 |
2022 | 506,674 |
Trade accounts payable | |
20181) | 31,137 |
20191) | 31,319 |
20201) | 42,549 |
2021 | 72,598 |
2022 | 97,277 |
Provisions | |
20181) | 47,943 |
20191) | 53,553 |
20201) | 62,579 |
2021 | 57,281 |
2022 | 70,837 |
Contract liabilities | |
20181) | 112,228 |
20191) | 104,852 |
20201) | 88,914 |
2021 | 145,537 |
2022 | 329,058 |
Other liabilities3) | |
20181) | 41,208 |
20191) | 48,925 |
20201) | 51,874 |
2021 | 69,143 |
2022 | 66,217 |
Total stockholders' equity | |
20181) | 426,380 |
20191) | 478,613 |
20201) | 724,456 |
2021 | 1,377,685 |
2022 | 1,187,185 |
Total liabilities and stockholders' equity | |
20181) | 771,361 |
20191) | 1,180,361 |
20201) | 1,462,337 |
2021 | 2,235,161 |
2022 | 2,257,247 |
20181) | |
20191) | |
20201) | |
2021 | |
2022 | |
Personnel data: | |
20181) | |
20191) | |
20201) | |
2021 | |
2022 | |
Employees as of 31 December | |
20181) | 2,617 |
20191) | 3,030 |
20201) | 3,572 |
2021 | 4,198 |
2022 | 4,952 |
20181) | |
20191) | |
20201) | |
2021 | |
2022 | |
Per share (in €): |
|
20181) | |
20191) | |
20201) | |
2021 | |
2022 | |
Result (basic/diluted) | |
20181) | 0.56/0.57 |
20191) | 0.25/0.25 |
20201) | 0.04/0.04 |
2021 | 1.30/1.30 |
2022 | (0.99)/(0.99) |
1) 2018 - 2020 restated for IAS 19
2) Consist of tax receivables, deferred tax assets, contract assets, prepaid expenses, equity investments, other long-term investments and other financial assets
3) Consist of tax receivables, deferred tax assets, contract assets, prepaid expenses, equity investments, other long-term investments and other financial assets
Guidance 2023
(as of 30 September 2023)
Guidance 2023
Guidance 2023 at constant fx-rates1)
Full-year 20222)
€ 750-790 m
€ 765-805
€ 751 m
€ 60-80 m
€ 70-90
€ 101 m
€ 60-70 m
-
€ 70 m
Group revenues |
|
Guidance 2023 | € 750-790 m |
Guidance 2023 at constant fx-rates1) | € 765-805 |
Full-year 20222) | € 751 m |
Adjusted Group EBITDA |
|
Guidance 2023 | € 60-80 m |
Guidance 2023 at constant fx-rates1) | € 70-90 |
Full-year 20222) | € 101 m |
Unpartnered R&D expenses3) | |
Guidance 2023 | € 60-70 m |
Guidance 2023 at constant fx-rates1) | - |
Full-year 20222) | € 70 m |
1) EUR/US$ 1.05; EUR/GBP 0.85
2) 2022 including M&A impact
3) No material fx-effects as most R&D efforts are carried out in € area
TOP